LOREN CALDERONE: Open Payments
NPI 1437763299 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 36 payments from 13 companies in 2025. Trend: 2023 $348 · 2024 $572 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 7 | $136 |
| Otsuka America Pharmaceutical, Inc. | 5 | $131 |
| Amgen Inc. | 5 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Travere Therapeutics, Inc. | 2 | $75 |
| Apellis Pharmaceuticals, Inc. | 2 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Ardelyx, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $38 |
| KYOWA KIRIN, INC. | 1 | $37 |
Products named: VELPHORO, FARXIGA, JYNARQUE, Empaveli, Kerendia, KRYSTEXXA, IBSRELA, JARDIANCE.
Industry payments across IN — which companies pay providers there.
